Search for: "Apotex"
Results 601 - 620
of 1,051
Sorted by Relevance
|
Sort by Date
6 Nov 2007, 9:57 pm
The letters from Sandoz and Apotex essentially mirror HPM's letter. [read post]
23 Apr 2007, 6:02 am
Mylan will continue to assert that even Apotex should either be blocked by Mylan’s 180-day exclusivity or not be approved during the pediatric exclusivity period based on multiple prior FDA rulings. [read post]
18 May 2014, 9:23 pm
Apotex (Fed. [read post]
1 Apr 2013, 8:29 am
.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
18 Nov 2009, 4:57 am
Apotex Inc. et al. [read post]
18 Aug 2010, 12:19 am
Apotex Pty Ltd; CSL Limited v. [read post]
12 Oct 2015, 7:41 am
Apotex: Whether an action seeking a declaration judgment of non-infringement presents a justiciable case or controversy under Article III of the Constitution where the patent at issue was previously disclaimed and thus cannot be enforced. [read post]
10 Nov 2014, 4:00 am
Excess CopyrightLast Minute Discontinuance of Patent Case on “Promised Utility” in Supreme Court of Canada In a very unusual development in a case that promised to be very interesting and important both domestically and internationally, Apotex has filed a notice of discontinuance literally on the day before and figuratively on the steps into the Court in its appeal against Sanofi in the Supreme Court of Canada that was to have been heard earlier today in Apotex et al… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
1 Dec 2009, 9:45 am
Apotex Corporation and Apotex Inc. [read post]
17 Jul 2017, 9:41 am
Apotex Inc., 687 F.3d 1362, 1369 (Fed. [read post]
26 Aug 2010, 3:00 am
In attempt to dislodge the injunction, Apotex has sought patent reexamination. [read post]
28 Oct 2009, 6:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) Vigamox (Moxifloxacin) - US: District Court S D New York finds Teva infringed Alcon's patent covering Vigamox (Patent Docs) (IP Factor) Alphagan (Brimonidine) - US: District Court Delaware rules that… [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings)… [read post]
20 Jul 2011, 4:04 am
(Spicy IP) US: Multicell Technologies receives stem cell patent (Patent Docs) US: FDA’s NDI guidance and the 18-year cycle of correcting regulatory overreach (FDA Law Blog) Products Adenoscan (Adenosine) – US: Astellas settles Adenoscan patent suit with Sagent and Strides Arcolab (Patent Docs) Angiomax (Bivalirudin) – US: The MDCO PTE decision: In play on Capitol Hill and in action at the PTO (FDA Law Blog) Cipralex (Escitalopram) – Austria: SPCs and Escitalopram in… [read post]
10 Dec 2007, 1:49 pm
He first dealt with Apotex's position that it could not do a CBE, disputing the reliance on 21 C.F.R. 314.150 cited by Kepple. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]
19 Jan 2011, 2:00 am
– Health Care Reform Bill (Patent Baristas) US: Academic study supports longer data exclusivity term for conventional drugs (Patent Docs) US: PTO sued after denying ‘mildly tardy’ second interim PTE request: Genetics & IVF Institute v Kappos (FDA Law Blog) US: AMP v USPTO – Appellees’ brief (Patent Docs) Products Avodart (Dutasteride) – US: GlaxoSmithKline file patent infringement complaint against Anchen following Para IV certification (Patent Docs)… [read post]
25 Mar 2024, 4:36 am
Teva & Apotex’s Arguments Against Certiorari Vanda forfeited its “predictability” argument by not raising it below. [read post]
17 Jan 2018, 9:04 am
Apotex Inc. 2017 CSC 36 . [read post]
